Serum concentrations of laminin-P1 in thrombotic microangiopathy: Usefulness as an index of activity and prognostic value

Journal of the American Society of Nephrology

Volumn 11, Issue 3, 2000, Pages 434-443

  Segarra, Alfons ^a   Simó, Rafael ^a   Masmiquel, Lluis ^a   Segura, Rosa M ^a   Fonollosa, Vicens ^a   Huguet, Pere ^a   Majo, Joaquim ^a   Piera, Lluis ^a   Schwartz, Simó ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0034091776     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Jain R, Chartash E, Susin M, Furie R: Systemic lupus erythematosus complicated by thrombotic microangiopathy. Semin Arthritis Rheum 24: 173-182, 1994
2. Moake JL: Thrombotic thrombocytopenic purpura. Thromb Haemost 74: 240-245, 1995
3. Remuzzi G, Ruggenenti P: The hemolytic uremic syndrome. Kidney Int 47: 2-19, 1995
4. Ruggenenti P, Remuzzi G: Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am 4: 219-241, 1990
5. Nesher G, Hanna VE, Moore TL, Hersh M, Osborn T: Thrombotic microangiopathic haemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 24: 165-172, 1994
6. Symmers WSTC: Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). Br Med J 2: 897-903, 1952
7. Berkowitz LR, Dalldorf FG, Blatt PM: Thrombotic thrombocytopenic purpura: A pathology review. JAMA 241: 1709-1710, 1979
8. Ridolfi RL, Bell WR: Thrombotic thrombocytopenic purpura: Report of 25 cases and review of the literature. Medicine 60: 413-428, 1981
9. Tarsio JF, Reger LA, Furcht LT: Molecular mechanisms in basement membrane complications of diabetes: Alterations in heparin, laminin, and type IV collagen association. Diabetes 37: 532-539, 1988
10. Timpl R, Brown JC: The laminins. Matrix Biol 14: 275-281, 1994
11. Brocks DG, Strecker H, Neubauer HP, Timpl R: Radioimmunoassay of laminin in serum and its application to cancer patients. Clin Chem 32: 787-791, 1986
12. Rochlitz CH, Hasslacher CH, Brocks DG, Hermann R: Serum concentration of laminin and course of the disease in patients with various malignancies. J Clin Oncol 5: 1424-1429, 1987
13. Gabrielli GB, Capra F, Casaril M, Corrocher R, Colombari R, De Sandre G: Serum laminin P1 in chronic viral hepatitis: Correlations with liver histological activity and diagnostic value. Clin Chim Acta 252: 171-180, 1996
14. Simó R, Masmiquel L, García-Pascual L, Burgos R, Mateo C, Segura RM, Mesa J: Serum concentrations of laminin-P1 in diabetes mellitus: Usefulness as an index of diabetic microangiopathy. Diabetes Res Clin Pract 32: 45-53, 1996
15. Kwaan HC: Miscellaneous secondary thrombotic microangiopathy. Semin Hematol 24: 141-147, 1987
16. Subcommittee for Scleroderma: Criteria of the ARA Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581-590, 1980
17. Le Roy EC, Black C, Fleischmajer R: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15: 202-205, 1988
18. Steen VD, Costantino JP, Shapiro AP, Medsger TA: Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme inhibitors. Ann Intern Med 113: 352-357, 1990
19. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ: The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1276, 1982
20. Bader H, Meyer DS: The size of juxtaglomerular apparatus in diabetic glomerulosclerosis and its correlation with arteriosclerosis and arterial hypertension: A morphometric light microscopic study on human renal biopsies. Clin Nephrol 8: 308-311, 1977
21. Xu Y, Hagege J, Mougenot B, Sraer JD, Rønne E, Rondeau E: Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int 50: 2011-2019, 1996
22. Engvall E: Laminin variants: Why, where and when? Kidney Int 43: 2-6, 1993
23. Iwahashi M, Yamoto M, Yamashita K, Nakano R, Ooshima A: Increased serum levels of type IV collagen and laminin in a patient with a giant retroperitoneal schwannoma. Pathol Int 45: 287-291, 1995
24. Sakai T, Hijikata T: Structural specializations of the basement membrane and their mechanical relevance to the kidney. Contrib Nephrol 95: 34-47, 1991
25. Rose M, Eldor A: High incidence of relapses in thrombotic thrombocytopenic purpura: Clinical study of 38 patients. Am J Med 83: 437-444, 1987
26. Rose M, Rowe JM, Eldor A: The changing course of thrombotic thrombocytopenic purpura and modern therapy. Blood Rev 7: 94-103, 1993
27. Clarkson AR, Thomas AC: Renal disease in scleroderma and mixed connective tissue disease. In: International Yearbook of Nephrology 1994, edited by Andreucci V, Fine LG, New York, Oxford Medical Publications, 1993, pp 33-45
28. Gressner AM, Kropf J: Estimation of the production rates of serum aminoterminal propeptide of type III procollagen and laminin in human fibrotic liver. J Clin Chem Clin Biochem 25: 553-559, 1987
29. Smedsrod B, Paulsson M, Johansson S: Uptake and degradation in vivo and in vitro of laminin and nidogen by rat liver cells. Biochem J 261: 37-42, 1989
30. Horikoshi S, Koide H: Serum laminin-P1 fragment concentration in renal diseases. Clin Chim Acta 196: 185-192, 1991
31. Segarra A, Masmiquel LL, Simó R, Segura RM, Sauri R, Piera LL: Which factors account for increased serum laminin levels in patients with chronic renal diseases? Nephron 72: 359-360, 1996
32. Segarra A, Simó R, Marti R: Serum laminin level and disease activity in primary membranous and membranoproliferative glomerulonephritis: A prospective follow-up. Nephron 73: 367, 1996
33. Bergstein J, Riley M, Bang NU: Role of plasminogen inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. N Engl J Med 327: 755-759, 1992